ArticleBioengineered2021

N-terminal prohormone B-type natriuretic peptide variability acts as a predictor of poor prognosis in patients with cardiorenal syndrome type 2.

Mingming Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.